UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                     Washington, D. C. 20549
                           FORM 10-QSB


(x)  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
     EXCHANGE ACT OF 1934

For the quarterly period ended      March 31, 2002
                                -----------------------

( )  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
     EXCHANGE ACT OF 1934


For the transition period from______________________ to _________________.

Commission File number    000-29057
                       ------------------

                   ALTRIMEGA HEALTH CORPORATION
        -------------------------------------------------
        (Exact name of registrant as specified in charter)

        Nevada                                            87-0631750
 ------------------------------                        ----------------
(State or other jurisdiction of                       (I.R.S. Employer
incorporation or organization)                        Identification No.)


 5600 Bell Street, Suite 111, Amarillo, Texas                 79106
--------------------------------------------------          ---------
(Address of principal executive offices)                   (Zip Code)

                          (806) 331-6398
        -------------------------------------------------
        Registrant's telephone number, including area code


        -------------------------------------------------
      (Former name, former address, and former fiscal year,
                  if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports),  Yes [x ]  No [ ] and (2) has
been subject to such filing requirements for the past 90 days. Yes [x]  No [ ]

              APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the last practicable date

                  Class                Outstanding as of March 31, 2002
           ---------------------     ------------------------------------
           Common  Stock, $0.001                 22,020,000



                               -1-

<PAGE>


                              INDEX

                                                                     Page
                                                                     Number
                                                                     --------
PART I.

    ITEM 1.  Financial Statements (unaudited).............................3

             Balance Sheets...............................................4
             March 31, 2002 and December 31, 2001

             Statements of Operations
             Three months ended March 31, 2002 and 2001...................5
             and the period September 8, 1998 to March 31, 2002

             Statements of Cash Flows
             Three months ended March 31, 2002 and 2001...................6
             and the period September 8, 1998 to March 31, 2002

             Notes to Financial Statements................................7

    ITEM 2.  Management's Discussion and Analysis or Plan of Operations...9

PART II.     Other Information...........................................10

             Signatures..................................................10


                                     -2-

<PAGE>
<PAGE>

PART I - FINANCIAL INFORMATION

_____________________________________________________________________________

ITEM 1. FINANCIAL STATEMENTS
_____________________________________________________________________________


The accompanying   balance sheets of Altrimega Health Corporation (
development stage company)  at  March 31, 2002 and December 31, 2001, and the
related statements of operations and cash flows for the three   months ended
March 31, 2002 and 2001 and the period from September 8, 1998  to March 31,
2002,  have been prepared by the Company's management in conformity with
accounting principles generally accepted in the United States of America.  In
the opinion of management, all adjustments considered necessary for a fair
presentation of the results of operations and financial position have been
included and all such adjustments are of a normal recurring nature.

Operating  results for the quarter ended March 31, 2002, are not necessarily
indicative of the results that can be expected for the year ending December
31, 2002.











                               -3-

<PAGE>
<PAGE>



                   ALTRIMEGA HEALTH CORPORATION
                   (Development Stage Company)
                          BALANCE SHEETS
               March 31, 2002 and December 31, 2001

==============================================================================

                                                    Mar 31,       Dec 31,
                                                     2002          2001
                                                 ------------- -------------
ASSETS
CURRENT ASSETS
 Cash                                            $          -  $           -
                                                 ------------- -------------
   Total Current Assets                          $          -  $           -
                                                 ============= =============


LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
  Account payable                                $     10,895  $           -
                                                 ------------- -------------
   Total Current Liabilities                           10,895              -
                                                 ------------- -------------

STOCKHOLDERS' EQUITY
  Preferred stock
    10,000,000 shares authorized at $0.001
    par value; none outstanding                              -             -
  Common stock
    50,000,000 shares authorized at $0.001
    par value; 22,020,000 shares issued and
    outstanding                                         22,020        22,020
  Capital in excess of par value                       117,135       117,135
  Deficit accumulated during the development stage    (150,050)     (139,155)
                                                 ------------- -------------

   Total Stockholders' Deficiency                      (10,895)            -
                                                 ------------- -------------

                                                 $           - $           -
                                                 ============= =============


The accompanying notes are an integral part of these financial statements.

                               -4-

<PAGE>
<PAGE>

                    ALTRIMEGA HEALTH CORPORATION
                   (Development Stage Company)
                     STATEMENTS OF OPERATIONS
   For the Three Months Ended March 31, 2002 and 2001 and the
  Period September 8, 1998 (Date of Inception) to March 31, 2002

==============================================================================

                                    Mar 31,       Mar 31,    Sept 8, 1998 to
                                     2002          2001       Mar 31, 2002
                                 ------------  ------------  --------------
REVENUES                         $          -  $          -  $        9,703
                                 ------------  ------------  --------------
EXPENSES

  Product Development                       -         8,000          76,692
  Administrative                       10,895         2,940          81,767
  Depreciation                              -           140           1,294
                                 ------------  ------------  --------------
                                       10,895        11,080         159,753
                                 ------------  ------------  --------------
NET LOSS                         $    (10,895) $    (11,080) $     (150,050)
                                 ============  ============  ==============
NET LOSS PER
 COMMON SHARE

 Basic                           $          -  $          -
                                 ============  ============
AVERAGE  OUTSTANDING SHARES

 Basic (stated in 1000's)              22,020        20,504
                                 ============  ============





The accompanying notes are an integral part of these financial statements

                               -5-


<PAGE>
<PAGE>
                   ALTRIMEGA HEALTH CORPORATION
                   (Development Stage Company)
                     STATEMENT OF CASH FLOWS
    For the Three Months Ended March 31, 2002 and 2001 and the
  Period September 8, 1998 (Date of Inception) to March 31, 2002

=============================================================================

                                    Mar 31,       Mar 31,    Sept 8, 1998 to
                                     2002          2001       Mar 31, 2002
                                 ------------  ------------  --------------
CASH FLOWS FROM
 OPERATING ACTIVITIES

  Net loss                       $    (10,895) $    (11,080) $     (150,050)

  Adjustments to reconcile net
  loss to net cash provided by
  operating activities

     Depreciation                           -           140               -
     Changes in accounts payable       10,895        31,963          48,558
     Contributions of capital -
       expenses                             -             -           4,492
                                 ------------  ------------  --------------

     Net Cash Received (Used)
      in Operations                         -        21,023         (97,000)
                                 ------------  ------------  --------------
CASH FLOWS FROM INVESTING
 ACTIVITIES

  Advance deposit - lease                   -       (20,000)              -
                                 ------------  ------------  --------------
CASH FLOWS FROM FINANCING
 ACTIVITIES

  Proceeds from issuance of
  common stock                              -             -          97,000
                                 ------------  ------------  --------------

Net Increase (decrease) in Cash             -         1,023               -

Cash at Beginning of Period                 -            33               -
                                 ------------  ------------  --------------
Cash at End of Period            $          -  $      1,056  $            -
                                 ============  ============  ==============

NON CASH FLOWS FROM OPERATING AND INVESTING ACTIVITIES

Contributions to capital -
 expenses - related parties - 2001             $      4,492
                                               ============
Contributions to capital -
 forgiveness of debt - related party - 2001    $     37,663
                                               ============

The accompanying notes are an integral part of these financial statements.

                               -6-

<PAGE>
                   ALTRIMEGA HEALTH CORPORATION
                   (Development Stage Company)
                  NOTES TO FINANCIAL STATEMENTS

=============================================================================

1.   ORGANIZATION

The Company was incorporated under the laws of the State of Nevada on
September 8, 1998 with the name of  Mega  International  Health  Corporation
with authorized common stock of 50,000,000 shares with a par value of $0.001
and preferred stock of 10,000,000 shares with a par value of $0.001. The board
of directors will determine the powers and rights of the preferred stock when
it is issued. On June 23, 1999 the name was changed to Altrimega Health
Corporation. The Company was organized for the purpose of marketing
nutritional products.

The Company is in the development stage.

On March 5, 2001 the Company completed a forward stock split of four shares
for each outstanding share.  This report has been prepared showing after stock
split shares from inception.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Methods

The Company recognizes income and expenses based on the accrual method of
accounting.

Dividend Policy

The Company has not  adopted a policy regarding payment of dividends.

Income Taxes

On March 31, 2002 the Company  had   a  net operating loss carryforward   of
$150,050. The  tax benefit of approximately $45,015 from the loss carry
forward  has been fully offset by a valuation reserve because the use of the
future tax benefit is doubtful, since the Company has no operations on which
to project  future  net profits. The loss carryover will expire in 2022.

Basic and Diluted Net Income (Loss) Per Share

Basic net income (loss) per share amounts are computed based on the weighted
average number of shares actually outstanding. Diluted net income (loss) per
share amounts are computed using the weighted average number of common shares
and common equivalent shares outstanding as if shares had been issued on the
exercise of the preferred share rights unless the  exercise becomes
antidilutive and then only the basic per share amounts are shown in the
report.







                               -7-
<PAGE>
<PAGE>

                 ALTRIMEGA   HEALTH   CORPORATION
                   ( Development Stage Company)
            NOTES TO FINANCIAL STATEMENTS (Continued)

=============================================================================

2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Financial Instruments

The carrying amounts of financial instruments  are considered by management to
be their estimated fair values.

Estimates and Assumptions

Management uses estimates and assumptions in preparing financial statements in
accordance with generally accepted accounting principles.  Those estimates and
assumptions affect the reported amounts of the assets and liabilities, the
disclosure of contingent assets and liabilities, and the reported revenues and
expenses.  Actual results could vary from the estimates that were assumed in
preparing these financial statements.

Comprehensive Income

The Company has adopted Statement of Financial Accounting Standards No. 130.
The adoption of this standard had no impact on the total stockholder's equity.

Other Recent Accounting Pronouncements

The Company does not expect that the adoption of other recent accounting
pronouncements to have any
material impact on its  financial statements.

3.  SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES

Officers-directors  of the Company have acquired 28% of the outstanding common
stock. A former president-director has made a contribution to the capital by
the forgiveness of debt due him from the Company of $37,663. Former officers-
directors have made contributions to the capital of the Company by the payment
of expenses incurred by the Company of $4,492.

4.  GOING CONCERN

The company will need additional working capital to service its debt and for
its future  planned activity and continuation of the Company  as a going
concern is dependent upon obtaining sufficient  working capital to be
successful in  that effort and the management of the Company has developed a
strategy, which it believes will accomplish this objective through additional
equity funding, and long term financing, which will enable the Company to
operate for the coming year.








                               -8-
<PAGE>
<PAGE>

-----------------------------------------------------------------------------
ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS
-----------------------------------------------------------------------------

Proposed Acquisition of Advanced Wireless Messaging, Inc.
---------------------------------------------------------
On December 11, 2001, we entered into an Exchange Agreement with Advanced
Messaging Wireless, Inc., of Amarillo, Texas ("Advanced"). Advanced is a Texas
corporation and formed in April 2001 as a marketing organization that offers
wireless and communications products to consumers through its retail outlets.
Advanced has entered into a licensing agreement with Nextel Communications to
resell their services in the Southwestern United States.

Set forth below is a summary of the key terms of the Exchange Agreement
entered into with Advanced. The following summary is subject to the detailed
provisions of the Exchange Agreement that has been filed with the Commission
as an exhibit to a current report on Form 8-K, on March 27, 2002, and is
incorporated herein by this reference.

 1) Exchange of Interests.  Subject to the conditions set forth in the
Exchange Agreement, on the Closing Date (as defined below), the Advanced
Stockholders will exchange all of their respective ownership interest in
Advanced (the "Advanced Shares"), which interests shall represent 100% of the
ownership interest in Advanced, for an aggregate of 10,000,000 restricted
shares of Altrimega common stock (the "Altrimega Common Stock").  Such shares
of Altrimega Common Stock shall be issued pro rata based on the percentage of
ownership interest held as of the Closing Date.

 2) Operation as Wholly-Owned Subsidiary.  After giving effect to the
transaction, Altrimega will 100% of the ownership interest of Advanced and
Advanced will be a wholly-owned subsidiary of Altrimega operating under the
name Advanced Messaging Wireless, Inc., or such other name as Altrimega may
determine.

 3) Closing.  The Closing contemplated under the Exchange Agreement shall be
held at a mutually agreed upon time and place on the completion and
satisfaction of the conditions set forth in Articles IV and V of the Exchange
Agreement (the "Closing Date").

 4) Conditions Precedent to Obligations of Advanced.   The obligations of
Advanced under the Exchange Agreement are subject to, among other things,
Altrimega shareholders' approval.

 5) Conditions Precedent to Obligations of Altrimega. The obligation of
Altrimega to complete the terms of the Exchange Agreement are contingent on,
among other things, Advanced completing the acquisition of Excel Wireless,
Inc. ("Excel") and Communication Syndicate, Inc. ("CSI"), two retail
communications services providers. Advanced is to make the acquisitions in
exchange for shares of the capital stock of Advanced and/or cash, so that on
the Closing Date, any shares of capital stock issued by Advanced in connection
with the acquisitions of Excel and CSI will be exchanged pro rata by the
Advanced Stockholders in exchange for Altrimega Common Stock. In addition,
Advanced shall provide Altrimega with the financial information for Excel and
CSI required under Item 310(c) of Regulation S-B, promulgated under the
Securities Act. Advanced must also obtain shareholder approval.





<PAGE>

Plan of Operation
-----------------
We are considered a development stage company and we had no assets or working
capital and no operations or income during the three month period ended March
31, 2002. We anticipate that we will require only nominal capital to maintain
our corporate viability and necessary funds will most likely be provided by
our existing shareholders or our officers and directors in the immediate
future until the completion of a proposed share exchange with Advanced.

Liquidity and Capital Resources
--------------------------------
As of March 31, 2002, we had no assets and liabilities of $10,895.

Results of Operations
----------------------
We are a development stage company and had limited operations during the the
three month period ended March 31, 2002, wherein we incurred $10,895 in
administrative expenses. Since our inception (September 8, 1998), we have
generated net losses of $150,050, based on limited operating capital. As a
result, the report of our auditor at December 31, 2001 contains a going
concern modification as to our ability to continue as a going concern. Our
continuation as a going concern is dependent on our ability to meet our
obligations and obtain additional debt or equity financing required until it
complete the proposed share exchange with Advanced and are able to obtain
profitability through its operations. Until such time as the proposed share
exchange with Advance is consummated we have taken the following steps to
revise our operating and financial requirements in an effort to enable us to
continue in existence:

     + We have reduced administrative expenses to a minimum by consolidating
management responsibilities to our chief executive officer.

     + We will seek, if required, either equity or further debt funding from
principal shareholders.

     + We will attempt to obtain the professional services of third-parties
through favorable financing arrangements or payment by the issuance of our
common stock.

We believe that the foregoing plan will enable us to generate sufficient funds
to continue its operations for the next twelve months.

                   PART II - OTHER INFORMATION
ITEM 1.  LEGAL PROCEEDINGS

We are not aware of any material pending or threatened litigation.

ITEM 2.  CHANGES IN THE RIGHTS OF THE COMPANY'S SECURITY HOLDERS
   None.

ITEM 3.  DEFAULT BY THE COMPANY ON ITS SENIOR SECURITIES
   None.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS
   None.

ITEM 5.  OTHER INFORMATION
   None

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits
    --------
    None.

(b) Reports on Form 8-K
    -------------------
(1)  On March 27, 2002, we filed a current report on Form 8-K, reporting
certain Regulation FD disclosure under Item 9, relating to a series of press
releases issued by us between November 2001 and January 2002, and other
information relating to a preliminary schedule 14C and related preliminary
information statement filed by us on January 31, 2002.

(2)  On March 27, 2002, we filed a current report on Form 8-K, reporting a
change in our control under Item 1, for an event that occurred November 9,
2001.



                            SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of  1934, we have
duly caused this report to be signed on our behalf by the undersigned,
thereunto duly authorized.

                                     ALTRIMEGA HEALTH CORPORATION

Date: May 15, 2002                   By /s/ Kelley Magee
                                     ------------------------------------
                                   Kelley Magee, President and Principal
                                     Accounting Officer